← All trials
NCT01577368
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2011
- Primary completion
- Jan 1, 2014
- Completion date
- Aug 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 76
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Fundación Pública AndaluzaLead sponsor
- Hospital Son EspasesCollaborator
- Hospital Son LlatzerCollaborator
- Hospital Infanta SofiaCollaborator
- University of SevilleCollaborator
- Hospital Universitario Virgen MacarenaCollaborator
- Complejo Hospitalario de Especialidades Juan Ramón JimenezCollaborator
- University Hospital Virgen de las NievesCollaborator
- Hospital Universitario Ntra. Sra. de La CandelariaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.